The global automated liquid handling technologies market size was valued at USD 1.01 billion in 2017. It is estimated to register a CAGR of 9.4% during the forecast period. Introduction of novel automated liquid handling workstations for non-contact dispensing is expected to drive the market.
Over the years, contact dispensing has gained wide acceptance due to its reliability, simplicity, and low cost. However, liquid handling needs are observed to be changing with reduction in sample volume. Surface adhesion is the most prominent factor that affects liquid handling performance at micro- to nanoliter sample volume.
Manufacturers are developing workstations based on different technologies for dispensing without surface adhesion. These technologies include ultrasound, piezoelectric, and solenoid. For instance, LABCYTE INC. uses Echo acoustic liquid handling technology in its products to offer non-contact dispensing.
In addition, effective miniaturization of assay platforms reduces workflow expenditure by reduction in use of expensive reagents. Increasing development of acoustic liquid handling platforms, which enable faster processing, is likely to stoke the growth of the market. Growing trend of automation and advantages of automated liquid handling over manual handling are also providing a fillip to the market.
Based on product, the market has been bifurcated into automated liquid handling workstations and reagents and consumables. Workstations have been reviewed based on their assembly and type. On the basis of assembly, they can be segmented into standalone and integrated workstations and based on type, they can be divided into multipurpose, pipetting, specialized liquid handlers, and workstation module.
Growing competition among pharmaceutical companies and their pursuit to develop novel drugs are fueling the adoption of automated workstations. Small footprint and ability to provide accurate as well as faster serial dilution and plate replication are contributing to larger market penetration of standalone pipettors. Some of the common pipettors available in the market are Biotek’s Precision XS, Agilent’s Bravo, Beckman Coulter’s Biomek NX, Agilent’s Vprep, Hamilton’s NIMBUS, and TTP Labtech mosquito HTS.
Consumables account for a considerable cost to pharma companies & biotech laboratories. Higher prices of consumables coupled with recurring use of these products in workflow steps are playing a vital role in the growth of the reagents and consumables segment. However, increasing number of third party manufacturers for disposable tips that are compatible with automated systems is projected to reduce their adoption of conventional accessories over the years.
Over a million compounds are screened to identify a new drug candidate in a single drug discovery experiment. Various applications in drug discovery & ADME Tox include stepwise serial dilution over wide concentration range, selection and transfer of compounds for retest, and confirmatory & further analysis. The drug discovery and ADME Tox segment is poised to represent the leading share in the automated liquid handling technologies market throughout the forecast period. Ability to integrate different types of liquid handlers and stackers or incubators for enhancing throughput are the major advantages associated with the usage of automated liquid handling platforms in drug discovery.
Automated liquid handling is an essential part of cancer & genomic research as it requires dispensing protein or DNA solutions onto substrates or into microwells. Subsequent steps involving synthesis and analysis usually require dispensing of additional solutions. Use of manual liquid handling techniques for these steps becomes impractical & tedious. Adoption of automated liquid handling technologies for genomic and cancer research is anticipated to witness substantial growth in the coming years.
Automated liquid handlers are extensively used in drug discovery laboratories. High need to dispense liquid samples on different substrates and transfer them to containers of varying size has translated into rise in adoption in drug development & manufacturing. Owing to this increase in use of automation for drug screening and drug development, pharma & biotech companies are estimated to be the leading segment in the market in 2017.
Increasing outsourcing of pharma and biotech workflows is encouraging CROs & CMOs to enhance their work flow efficiency in compliance with regulatory requirements. Thereby, several CROs & CMOs are integrating automated liquid handling in their facilities. For instance, in September 2016, Vibalogics, a German CDMO enhanced operating capabilities with installation of Bosch ARF 1020 filling machine for automatic vial filling.
Furthermore, academic and research institutes involved in life science experiments, especially those involving gene sequencing, antibody testing, drug, screening, and protein crystallization, usually need to handle very small sample volumes. Thus, demand for automated methods such as sensor integrated robotic systems is expected to support revenue growth in the academic & research institutes segment.
North America was at the forefront of the market in 2017 owing to well-established distribution network of major market players and higher usage of advanced automation solutions. Demand for small volume genomic and proteomics analysis for life science research is further stimulating the growth of the regional market. Competitors in the region are collaborating with large academic universities & research centers in Europe to increase their revenue.
However, expanding base of local biotech companies, increasing funding support, and CFDA reform in China and price reform in Japan (affecting both off-patent and on patent products) are likely to foster the progress of the biopharmaceutical industry. Rapid progress of biopharma & biotechnology companies as well as contract organizations in countries such as Japan and China is projected to propel the market in Asia Pacific. The region is poised to exhibit the highest CAGR during the forecast period.
The market is consolidated with few market players having a larger market share. These key players include Analytik Jena AG; Hamilton Company; Aurora Biomed Inc.; Labcyte Inc.; Eppendorf AG; BioTek Instruments, Inc.; Agilent Technologies; Labnet International, Inc.; Gilson, Inc.; Beckman Coulter, Inc.; and Tecan Trading AG.
Competitors are involved in strategic partnerships with biotech companies to develop assays & tools in order to provide automated workflows to biopharmaceutical companies. For instance, in June 2018, Hamilton Robotics collaborated with WATERS for development of STARWorks for sample preparation workflows using WATER’s assays -Waters ProteinWorks and Waters GlycoWorks.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.3 billion |
Revenue forecast in 2025 |
USD 2.1 billion |
Growth Rate |
CAGR of 9.4% from 2018 to 2025 |
Base year for estimation |
2017 |
Historical data |
2014 - 2016 |
Forecast period |
2018 - 2025 |
Quantitative units |
Revenue in USD Million & CAGR from 2018 to 2025 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product, application, end user, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; Japan; China; Brazil; South Africa |
Key companies profiled |
Analytik Jena AG; Hamilton Company; Aurora Biomed Inc.; Labcyte Inc.; Eppendorf AG; BioTek Instruments, Inc.; Agilent Technologies; Labnet International, Inc.; Gilson, Inc.; Beckman Coulter, Inc.; Tecan Trading AG. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global automated liquid handling technologies market report on the basis of product, application, end user, and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
Automated Liquid Handling Workstations
By Assembly
Standalone Workstations
Integrated Workstations
By Type
Multipurpose Workstation
Pipetting Workstation
Specialized Liquid Handler
Workstation Module
Reagents & Consumables
Reagents
Accessories
Application Outlook (Revenue, USD Million, 2014 - 2025)
Drug Discovery & ADME-Tox Research
Cancer & Genomic Research
Bioprocessing/Biotechnology
Others
End-User Outlook (Revenue, USD Million, 2014 - 2025)
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Regional Outlook (Revenue, USD Million, 2014 - 2025)
North America
The U.S.
Canada
Europe
Germany
The U.K.
Asia Pacific
Japan
China
Latin America
Brazil
Middle East and Africa (MEA)
South Africa
b. The global automated liquid handling technologies market size was estimated at USD 1.2 billion in 2019 and is expected to reach USD 1.3 billion in 2020.
b. The global automated liquid handling technologies market is expected to grow at a compound annual growth rate of 9.4% from 2018 to 2025 to reach USD 2.1 billion by 2025.
b. North America dominated the automated liquid handling technologies market with a share of 39.6% in 2019. This is attributable to a well-established distribution network of major market players and higher usage of advanced automation solutions in the region.
b. Some key players operating in the automated liquid handling technologies market include Analytik Jena AG; Hamilton Company; Aurora Biomed Inc.; Labcyte Inc.; Eppendorf AG; BioTek Instruments, Inc.; Agilent Technologies; Labnet International, Inc.; Gilson, Inc.; Beckman Coulter, Inc.; and Tecan Trading AG.
b. Key factors that are driving the automated liquid handling technologies market growth include an increase in investment in drug development, clinical trials, and life sciences R & D, rapid adoption of automation, and ease of handling associated with the use.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
Biopharmaceutical innovators are at the forefront of the human response to the coronavirus pandemic. A significant number of major biotech firms are in the midst of a race to investigate the Sars-Cov-2 genome and prepare a viable vaccine for the same. As compared to the speed of response to SARS/MERs etc, the biotech entities are investigating SARs-Cov-2 at an unprecedented rate and a considerable amount of funds are being put into the R&D. With multiple candidates in trial, the public and private sectors are anticipated to work in unison for the foreseeable period, until a vaccine is developed for Covid-19. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.